Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery Cytokeratin 13

Path Created with Sketch.
Go to Cytokeratin 13 Normal Tissue GalleryGo back to Product Page
Anorectum - Squamous cell carcinoma with moderate to strong KRT13 positivity of suprabasal cells.
Anorectum – Squamous cell carcinoma with moderate to strong KRT13 positivity of suprabasal cells.
Colon - KRT13 negative colorectal adenocarcinoma.
Colon – KRT13 negative colorectal adenocarcinoma.
Esophgus - Squamous cell carcinoma with strong diffuse KRT13 positivity.
Esophgus – Squamous cell carcinoma with strong diffuse KRT13 positivity.
Kidney - KRT13 negative clear cell renal cell carcinoma.
Kidney – KRT13 negative clear cell renal cell carcinoma.
Larynx - Squamous cell carcinoma with intense KRT13 positivity of suprabasal cells.
Larynx – Squamous cell carcinoma with intense KRT13 positivity of suprabasal cells.
Lung - KRT13 negative adenocarcinoma.
Lung – KRT13 negative adenocarcinoma.
Lung - Squamous cell carcinoma with intense KRT13 positivity of all cells. KRT13 staining intensity increases from the basal cell layers to the center of invasive tumor cell nests.
Lung – Squamous cell carcinoma with intense KRT13 positivity of all cells. KRT13 staining intensity increases from the basal cell layers to the center of invasive tumor cell nests.
Ovary - Brenner tumor with strong KRT13 positivity of urothelial cells.
Ovary – Brenner tumor with strong KRT13 positivity of urothelial cells.
Penis - Squamous cell carcinoma exhibiting a strong diffuse KRT13 positivity of all tumor cells.
Penis – Squamous cell carcinoma exhibiting a strong diffuse KRT13 positivity of all tumor cells.
Pleura - KRT13 negative malignant mesothelioma.
Pleura – KRT13 negative malignant mesothelioma.
Prostate - KRT13 negative prostatic adenocarcinoma (Gleason 3+3=6).
Prostate – KRT13 negative prostatic adenocarcinoma (Gleason 3+3=6).
Salivary gland - Warthin tumor showing intense KRT13 positivity of a small fraction of (suprabasal) cells.
Salivary gland – Warthin tumor showing intense KRT13 positivity of a small fraction of (suprabasal) cells.
Skin - KRT13 negative basal cell carcinoma.
Skin – KRT13 negative basal cell carcinoma.
Skin - Squamous cell carcinoma with scattered KRT13 positive cells showing variable levels of expression (mosaic pattern).
Skin – Squamous cell carcinoma with scattered KRT13 positive cells showing variable levels of expression (mosaic pattern).
Thyroid - KRT13 negative papillary carcinoma.
Thyroid – KRT13 negative papillary carcinoma.
Urinary bladder - Non-invasive papillary urothelial carcinoma (pTa) showing strong diffuse KRT13 positivity.
Urinary bladder – Non-invasive papillary urothelial carcinoma (pTa) showing strong diffuse KRT13 positivity.
Urinary bladder - Strong KRT13 immunostaining in a muscle-invasive urothelial carcinoma.
Urinary bladder – Strong KRT13 immunostaining in a muscle-invasive urothelial carcinoma.
Uterine cervix - Squamous cell carcinoma showing strong KRT13 expression of suprabasal cells.
Uterine cervix – Squamous cell carcinoma showing strong KRT13 expression of suprabasal cells.
Vulva - Squamous cell carcinoma with intense KRT13 immunostaining of all cells.
Vulva – Squamous cell carcinoma with intense KRT13 immunostaining of all cells.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors